^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Penile Cancer

21h
TG4001.12: Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers (clinicaltrials.gov)
P1/2, N=143, Active, not recruiting, Transgene | Trial completion date: Dec 2025 --> Dec 2026
Trial completion date
|
Bavencio (avelumab) • tipapkinogene sovacivec (TG4001)
2d
Decoding the Cellular Heterogeneity and Malignant Progression of Human Penile Squamous Cell Carcinoma by Single-Cell RNA Sequencing. (PubMed, Adv Sci (Weinh))
Overall, we investigated the heterogeneity of TME from a single-cell perspective and demonstrated that SEMA3C serve as an effective biomarker for predicting lymph node metastasis and prognosis in PSCC. These findings may offer valuable insights for future therapeutic strategies.
Journal
|
POSTN (Periostin)
3d
New P2 trial
|
Lenvima (lenvatinib) • albumin-bound paclitaxel • Qibeian (iparomlimab/tuvonralimab)
6d
DEPECA-2: DEfeating PEnile CAncer-2 (clinicaltrials.gov)
P=N/A, N=80, Not yet recruiting, University Hospital Tuebingen
New trial
7d
Exploration of the Tumor Microenvironment and Immune Microenvironment in Penile Cancer (ChiCTR2500112915)
P=N/A, N=20, Not yet recruiting, The First Affiliated Hospital of Soochow University; The First Affiliated Hospital of Soochow University
New trial
|
CD74 (CD74 Molecule)
8d
Field effects in penile squamous cell carcinoma: Insights from Wnt-related protein expression. (PubMed, Clin Exp Dermatol)
This study provides the first evidence of molecular changes in peritumour tissue to demonstrate field effect in PeSCC, characterised by downregulation of Wnt4, upregulation of c-MYC, and altered spatial colocalisation of Wnt-related proteins in cancer-adjacent skin. These findings suggest that peritumoral tissues exhibit early molecular alterations that extend beyond the morphologically defined tumour margin. Recognising these changes may have implications for understanding tumour microenvironment conditioning and for the future development of biomarkers relevant to margin assessment in penile carcinogenesis.
Journal
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • CCND1 (Cyclin D1) • MMP7 (Matrix metallopeptidase 7)
8d
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic (clinicaltrials.gov)
P2, N=157, Active, not recruiting, M.D. Anderson Cancer Center | Trial completion date: Dec 2025 --> Dec 2028 | Trial primary completion date: Dec 2025 --> Dec 2028
Trial completion date • Trial primary completion date • Tumor mutational burden
|
PD-L1 (Programmed death ligand 1)
|
Keytruda (pembrolizumab)
10d
Geospatial and Cell Density Analysis Using Multiplex Immunofluorescence Reveals an Important Role of Clustering Patterns of Immunosuppressive Macrophages in Survival Outcomes of Penile Squamous Cell Carcinoma. (PubMed, Cancers (Basel))
Immune cell density and spatial organization within the TIME are associated with survival outcomes in PSCC. Favorable patterns involving helper T cells and M1 macrophages correlate with improved survival, whereas clustering of M2 macrophages is associated with poorer outcomes, supporting the relevance of spatial immune profiling in this disease.
Journal
|
CD4 (CD4 Molecule)
11d
Penile mucoepidermoid carcinoma lacking CRTC1/CRTC3-MAML2 fusion: a case report and review of the literature. (PubMed, Int Cancer Conf J)
The absence of the common MEC-associated fusion gene may indicate a more aggressive clinical course. Further accumulation of cases with detailed molecular characterization is crucial to clarify the pathogenesis, behavior, and optimal management strategies for this rare entity.
Journal
|
CRTC1 (CREB Regulated Transcription Coactivator 1) • MAML2 (Mastermind Like Transcriptional Coactivator 2)
16d
Intraepithelial Penile Lesions. (PubMed, Adv Anat Pathol)
Lastly, rare case reports of primary penile melanoma in situ have been reported. The lesions can involve either the skin or mucosa, with the glans penis being the most commonly reported site.
Journal
|
TP53 (Tumor protein P53) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • HRAS (Harvey rat sarcoma viral oncogene homolog)
|
TP53 mutation • PIK3CA mutation
16d
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors (clinicaltrials.gov)
P2, N=100, Active, not recruiting, Dana-Farber Cancer Institute | Trial completion date: May 2026 --> Dec 2026 | Trial primary completion date: Dec 2025 --> Jun 2026
Trial completion date • Trial primary completion date
|
Opdivo (nivolumab) • Yervoy (ipilimumab)
18d
GATA3 Is Underexpressed in Penile Neoplasia: Potential Implications in Diagnosis and Pathogenesis. (PubMed, Am J Surg Pathol)
HPV-associated PSCC had a more severe loss (91%) than HPV-associated PeIN (39%) (P=0.008). These findings suggest that GATA3 alterations may be an early event during tumorigenesis, and that this marker may represent a useful complement to p16 and p53 in the differential diagnosis of HPV-independent PeIN from benign mimickers.
Journal
|
GATA3 (GATA binding protein 3)